A randomised control trial of omega-3 fatty acid on platelet and endothelial function in patients with peripheral arterial disease

niversity of Aberdeen0 个研究点目标入组 150 人开始时间: 2005年5月4日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•All patients must be able to give fully informed consent, have an ABPI <0.8 and be on aspirin and a statin. If these patients are not on these medications they will be commenced and enrolled 6 weeks later.We wish to determine the adjuvant effects of omega 3 fatty acids in patients with PAD on what is considered to be routine medical therapy. All patients in this study will attend our nurse lead claudication clinic and strict attention will be paid to secondary risk factor prevention as per our local guidelines. These include measures to acheive the target blood pressure (<140/85), screening for diabetes, referral to smoking cessation clinic, nicotine replacement therapy and advice on exercise.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Patients with critical limb ischaemia, liver impairment, abnormal platelet count, diabetes mellitusand those on clopidogrel, warfarin and NSAIDS

发起方

niversity of Aberdeen